# Dose-ranging Study of Ramosetron for the Prevention of Nausea and Vomiting After Gynecologic Laparoscopic Surgery

> **NCT02478645** · PHASE4 · COMPLETED · sponsor: **Yonsei University** · enrollment: 177 (actual)

## Conditions studied

- Postoperative Nausea and Vomiting

## Interventions

- **DRUG:** ramosetron 0.3
- **DRUG:** ramosetron 0.45
- **DRUG:** ramosetron 0.6

## Key facts

- **NCT ID:** NCT02478645
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06-19
- **Primary completion:** 2016-02-06
- **Final completion:** 2016-02-06
- **Target enrollment:** 177 (ACTUAL)
- **Last updated:** 2017-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02478645

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02478645, "Dose-ranging Study of Ramosetron for the Prevention of Nausea and Vomiting After Gynecologic Laparoscopic Surgery". Retrieved via AI Analytics 2026-06-06 from https://api.ai-analytics.org/clinical/NCT02478645. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
